News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

GLCCC NCI T32 Postdoctoral Fellowship in Cancer Population Science – Cancer & Aging
Jul 4, 2025, 23:40

GLCCC NCI T32 Postdoctoral Fellowship in Cancer Population Science – Cancer & Aging

The Georgetown Lombardi Comprehensive Cancer Center (GLCCC) offers a 2–3-year NCI-funded T32 postdoctoral fellowship in Cancer Population Science, with a special emphasis on cancer and aging—preparing fellows for independent translational research careers across behavioral science, epidemiology, health services, survivorship, and more.

Eligibility Criteria:

  • U.S. citizens or permanent residents only.

  • PhD, MD, ScD, or DrPH in psychology, gerontology, geriatrics, epidemiology, demography, health services, or a related field.

  • Demonstrated interest in cancer research; prior cancer–related research experience preferred but not required.

Funding Details:

  • Duration: 2–3 years

  • Support: Competitive salary and benefits, plus funds for research support and conference travel.

  • Training Components: Full involvement in study design through manuscript preparation; didactic coursework; multidisciplinary grant writing; mentoring opportunities; optional psycho-oncology clinical supervision.

Deadline:

Applications are accepted on a rolling basis for start dates in Summer or Fall 2025. Early inquiry is encouraged.

Where to Go for Further Information & Application:

Apply and view program details.

Direct questions to the training program coordinator: [email protected]

behavioral science cancer Cancer and Aging epidemiology Health Disparities OncoDaily Oncology population science postdoc survivorship T32 translational research
Special Coverage
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience
Blog
Jul 9, 2025, 20:10
Every Person Living with NCDs Such as Cancer Has Access to the Treatment and Care They Need - UICC
Blog
Jul 9, 2025, 19:55
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models - NCI Division of Cancer Biology
Blog
Jul 9, 2025, 19:35
UF Health Cancer Center Welcomed Nearly 150 Middle and High School Science Teachers From Across the Southeast
Blog
Jul 9, 2025, 19:16
SIOP Provides Scholarships to Nurses Who Have Insufficient Resources to Participate and to Travel to Our Congress
Blog
Jul 9, 2025, 18:36
2nd Synergies Forum Marks Milestone for Pediatric and Young Adult Cancer Advocacy in Europe - ELLOK
Insight
Jul 9, 2025, 18:16
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Blog
Jul 9, 2025, 17:59
Afreen Shariff: Ready to Take Cancer Care to New Heights?
Blog
Jul 9, 2025, 17:48
Adrian Pogacian: New Developments in Scanxiety Live Webinar